All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
Chapter 11: Eye
Toggle Parent Pages
Print this page
Treatment of dry eye
Nutritional supplements for age-related macular degeneration
11.1 Administration of drugs to the eye
11.3 Anti-infective eye preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.5 Mydriatics and cycloplegics
11.6 Treatment of glaucoma
11.7 Local anaesthetics
11.8 Miscellaneous ophthalmic preparations
11.9 Contact lenses
Contact us about this page
11.6.3 Sympathomimetics
First Line
Second Line
Specialist
Hospital Only
Brimonidine is a selective alpha 2 stimulant licensed for use in patients for whom beta-blockers are inappropriate or as adjunctive therapy when intra-ocular pressure is inadequately controlled by other antiglaucoma therapy.
Brimonidine carries an allergy risk of around 20% usually seen after 4-6 months of use.
Brimonidine
- Eye drops 0.2% (£2.54 = 5ml)
Dose
- Apply twice a day
Brimonidine / Timolol
- Eye drops brimonidine 2mg/ml / timolol 5mg/ml (£15.71 = 5ml)
Dose
- Apply twice a day
Apraclonidine
- Eye drops 5mg/ml (5ml)
